Stenting could be effective for erectile disfunction; St. Jude moves forward with new TAVI method;

 @FierceMedDev: Illumina gains legal means to keep fighting a patent claim against Complete Genomics. News | Follow @FierceMedDev

 @MarkHFierce: Volcano Corp., a rumored acquisition target, has itself acquired a company. More | Follow @MarkHFierce

 @DamianFierce: Innovent Biologics is moving into WuXi PharmaTech's backyard with a new Chinese plant. Report | Follow @DamianFierce

> If Viagra fails, a stent in the pelvic artery could be a viable treatment for erectile dysfunction, new research concludes. Story

> Toshiba is launching a new CT system in the U.S. designed to reduce radiation exposure, but broaden the potential area that can be imaged during a session. Item

> Tryton Medical has completed enrollment in a pivotal clinical trial designed to evaluate its new side branch stent. Item

> In Australia, network changes could render useless more than 200,000 life-saving medical devices for the elderly and disabled. Article (sub. req.)

> St. Jude Medical ($STJ) reported the first patient implant for its Portico Transcatheter Aortic Heart Valve using the transapical delivery system. Release

> Patients with risk factors including advanced age, previous stroke and severe aortic stenosis are at a greater risk of experiencing another stroke or death after transcatheter aortic valve implementation assuming they suffer complications such as bleeding, a new study concludes. Story (reg. req.)

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com: Blockbuster buzz: 15 top therapies in late-stage development. Special Report | Follow @FierceBiotech

 @JohnCFierce: AstraZeneca, Pfizer partner on $100M drug research collaboration project. Report | Follow @JohnCFierce

 @RyanMFierce: Averting the next bapi bust? J&J exec prescribes new approach to Alzheimer's drug development. Story | Follow @RyanMFierce

> J&J preps case for quick FDA approval of new TB drug. News

> No, Minister: Disgruntled Novartis threatens to steer R&D away from U.K. Story

Pharma News

@FiercePharma: Pfizer slashes Viagra prices in Canada to compete with new generics. Cut = 25%. News | Follow @FiercePharma

> Roche to Cochrane critics: Let's compromise on Tamiflu data. News

> Ranbaxy trips over generic Lipitor. Story

> GSK socks $1B into emerging markets consumer business. Report

Biotech IT News

> Eisai's H3 Bio leans on bioinformatics as cancer researcher expands. Report

> NIH taps Northrop Grumman for $30M bioinformatics project. Article

> J&J exec prescribes adaptive approach to Alzheimer's drug development. Story

CRO News

> U.K. wants CRO input on clinical trial reforms. Report

> QPS boosts Phase I capabilities in Netherlands. News

> Innovent targets WuXi with biologics plan. Story

> ShangPharma stumbles over increased costs in Q3. Article

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.